U-Blot® Research Grade AnselamimabCat. No. WA1084Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AnselamimabCat. No. WA1084
U-Blot® Research Grade AnrukinzumabCat. No. WA1083
U-Blot® Research Grade AnpocoginCat. No. WA1082
U-Blot® Research Grade AnivovetmabCat. No. WA1081
U-Blot® Research Grade AnifrolumabCat. No. WA1080
U-Blot® Research Grade anflekitugCat. No. WA1079
U-Blot® Research Grade AnetumabCat. No. WA1078
U-Blot® Research Grade AndecaliximabCat. No. WA1077
U-Blot® Research Grade AnbenitamabCat. No. WA1076
U-Blot® Research Grade AnatumomabCat. No. WA1075
U-Blot® Research Grade anafiltamigCat. No. WA1074
U-Blot® Research Grade Amulirafusp AlfaCat. No. WA1073